China Biologics Products

Taibang Biologic Group, formerly publicly listed as China Biologic Products Holdings, is a China-based plasma-derived biopharmaceutical company focused on the research, manufacture, and sale of blood products and selected medical devices. The company markets more than 20 plasma product dosage forms spanning human albumin, immunoglobulins, and coagulation-factor products, and also operates non-plasma businesses including dura mater and neurosurgical-related medical devices. Its manufacturing footprint includes major production bases in Shandong and Guizhou, supported by plasma collection operations and in-house R&D. China Biologic was taken private in April 2021 and now operates as an active privately held group under the Taibang Biologic name.